Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 16OTHER_GOV 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 45Neoplasms 27Uterine Cervical Neoplasms 24Prostatic Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Stomach Neoplasms 18Carcinoma, Hepatocellular 16Multiple Myeloma 14Ovarian Neoplasms 11Recurrence 10Pancreatic Neoplasms 10Esophageal Squamous Cell Carcinoma 10Esophageal Neoplasms 9Leukemia, Myeloid, Acute 8Endometrial Neoplasms 8Lymphoma 7Lung Neoplasms 7Brain Neoplasms 7Liver Neoplasms 6Leukemia 6Disease 6Carcinoma, Ovarian Epithelial 6Triple Negative Breast Neoplasms 5Small Cell Lung Carcinoma 5Rectal Neoplasms 5Papillomavirus Infections 5Colonic Neoplasms 5Urinary Bladder Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × OTHER_GOV × Monoclonal Gammopathy of Undetermined Significance × Clear all
NCT07214324 2026-04-23

PNRR-2022-1237

Azienda USL Reggio Emilia - IRCCS

Recruiting
60 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡